000 01300 a2200325 4500
005 20250517044004.0
264 0 _c20160502
008 201605s 0 0 eng d
022 _a1537-6591
024 7 _a10.1093/cid/civ460
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChilukuri, Dakshina
245 0 0 _aThe Hollow Fiber System Model in the Nonclinical Evaluation of Antituberculosis Drug Regimens.
_h[electronic resource]
260 _bClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_cAug 2015
300 _aS32-3 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntitubercular Agents
_xadministration & dosage
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHumans
650 0 4 _aModels, Biological
650 0 4 _aMycobacterium tuberculosis
_xdrug effects
650 0 4 _aTuberculosis
_xdrug therapy
700 1 _aMcMaster, Owen
700 1 _aBergman, Kimberly
700 1 _aColangelo, Philip
700 1 _aSnow, Kerry
700 1 _aToerner, Joseph G
773 0 _tClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_gvol. 61 Suppl 1
_gp. S32-3
856 4 0 _uhttps://doi.org/10.1093/cid/civ460
_zAvailable from publisher's website
999 _c25122393
_d25122393